Figure 3
IgM-producing
abilities of CD27+IgD+B cells in SLE
and healthy control patients. Flow cytometry-purified
CD27+IgD+B cells from four healthy
donors and four active SLE cases (SLEDAI>5) were assessed
by ELISPOT (A) and real-time PCR (B) for IgM detection. Representative
charts and quantitation are shown (t-test, *P<0.05,
***P<0.001).